234 related articles for article (PubMed ID: 35236752)
1. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial).
Baiocchi G; Andrade CEMC; Ribeiro R; Moretti-Marques R; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Costa RLR; Kumagai LY; Badiglian-Filho L; Faloppa CC; Mantoan H; De Brot L; Dos Reis R; Goncalves BT
Int J Gynecol Cancer; 2022 May; 32(5):676-679. PubMed ID: 35236752
[TBL] [Abstract][Full Text] [Related]
2. A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.
Guo Y; Sun L; Chen X; Wen Q; Shao Z; Tang X; Shi X; Wang J; Zhang Y; Zhu T
BMC Cancer; 2023 Dec; 23(1):1184. PubMed ID: 38041023
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
[TBL] [Abstract][Full Text] [Related]
4. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020.
Obermair A; Nicklin J; Gebski V; Hayes SC; Graves N; Mileshkin L; Lin MY; Beale P; Baxter E; Robledo K; Salomon C; Hanna GB; Janda M
Int J Gynecol Cancer; 2021 Dec; 31(12):1595-1601. PubMed ID: 34728527
[TBL] [Abstract][Full Text] [Related]
5. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial).
Guan J; Xue Y; Zang RY; Liu JH; Zhu JQ; Zheng Y; Wang B; Wang HY; Chen XJ
J Gynecol Oncol; 2021 Jul; 32(4):e60. PubMed ID: 34085796
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
[TBL] [Abstract][Full Text] [Related]
8. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
[TBL] [Abstract][Full Text] [Related]
9. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
10. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
11. Impact of comorbidities and extent of lymphadenectomy on quality of life in endometrial cancer patients treated with minimally invasive surgery in the era of sentinel lymph nodes.
Dinoi G; Multinu F; Yost K; AlHilli M; Larish A; Langstraat C; Kumar A; Weaver AL; McGree M; Cheville A; Dowdy S; Mariani A; Glaser G
Int J Gynecol Cancer; 2023 Aug; 33(8):1227-1236. PubMed ID: 37419517
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
Emons G; Kim JW; Weide K; de Gregorio N; Wimberger P; Trillsch F; Gabriel B; Denschlag D; Kommoss S; Aydogdu M; Papathemelis T; Gropp-Meier M; Muallem MZ; Kühn C; Müller A; Frank M; Weigel M; Bronger H; Lampe B; Rau J; Schade-Brittinger C; Harter P
Int J Gynecol Cancer; 2021 Jul; 31(7):1075-1079. PubMed ID: 34226291
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE).
Park JY; Kim JH; Baek MH; Park E; Kim SW
J Gynecol Oncol; 2022 Nov; 33(6):e73. PubMed ID: 36047376
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
Tu H; Huang H; Xian B; Li J; Wang P; Zhao W; Chen X; Xie X; Wang C; Kong B; Xiao J; Zhang P; Liu J;
Int J Gynecol Cancer; 2020 Nov; 30(11):1829-1833. PubMed ID: 32973117
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of sentinel lymph node mapping for endometrial cancer.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
20. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
Yu R; Matthews BJ; Beavis AL
Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
